Compounds > ribavirin
Page last updated: 2024-08-16

ribavirin and Disease Models, Animal

ribavirin has been researched along with Disease Models, Animal in 115 studies

Research

Studies (115)

TimeframeStudies, this research(%)All Research%
pre-199012 (10.43)18.7374
1990's5 (4.35)18.2507
2000's37 (32.17)29.6817
2010's52 (45.22)24.3611
2020's9 (7.83)2.80

Authors

AuthorsStudies
Furuta, Y; Julander, JG; Shafer, K; Sidwell, RW1
Li, YH; Li, ZR; Liu, ZY; Shao, HY; Wang, B; Yi, H; You, XF; Zhao, LX1
Amberg, SM; Bolken, TC; Burgeson, JR; Cerruti, NR; Dai, D; Gharaibeh, DN; Hruby, DE; Larson, RA; Moore, AL1
Dai, GF; Liang, YB; Liu, HF; Liu, HM; Liu, LH; Liu, WS; Luo, J; Xie, XP; Xu, HW; Zhao, D; Zhao, LJ; Zheng, JX1
Braisted, J; Dranchak, P; Earnest, TW; Gu, X; Hoon, MA; Inglese, J; Oliphant, E; Solinski, HJ1
Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV1
Egawa, K; Fujii, H; Fukushi, S; Furuta, Y; Harada, S; Komeno, T; Kurosu, T; Lim, CK; Maeki, T; Morikawa, S; Nakajima, N; Saijo, M; Shimojima, M; Takayama-Ito, M; Tani, H; Taniguchi, S; Uda, A; Yamada, S; Yoshikawa, T1
Cheng, G; Ding, X; Ghaffari, AA; Ho, CM; Krutzik, PO; Miranda, D; Nolan, GP; Sanchez, DJ; Zhaozhi, Y1
Bose, D; Chatterjee, S; Holland, LA; Horner, RD; Janulewicz Lloyd, P; Kimono, D; Klimas, N; Lim, ES; Maqsood, R; Mondal, A; Seth, RK; Sullivan, K1
Adams, R; Brady, T; Cai, Y; Cheng, B; Cooper, K; de la Torre, JC; Hart, R; Iwasaki, M; Kuhn, JH; Kurtz, J; Liu, DX; Martínez-Sobrido, L; Nogales, A; Postnikova, EN; St Claire, M; Ye, C; Yu, S1
Barron, S; Barrot, L; Carbonnelle, C; de Lamballerie, X; Duthey, A; Guedj, J; Jacquot, F; Lacarelle, B; Madelain, V; Mentré, F; Mundweiler, S; Raoul, H; Solas, C; Thomas, D; Vallvé, A1
Claus, M; Dauby, N; Dechamps, P; Gérard, M; Günther, S; Konopnicki, D; Mahieu, R; Malvy, D; Martin, C; Martiny, D; Morales, MA; Nasreddine, R; Perandones, C; Roman, A; Schuldt, G; Stevens, E; Swaan, C; Van den Wijngaert, S; Van Praet, S; Vandenberg, O; Veliziotis, I; Vlieghe, E1
Chu, JN; Collins, J; Eweje, F; Faiz, MT; Gwynne, D; Hayward, A; Hess, K; Hua, T; Ishida, K; Katz, S; Koeppen, R; Langer, R; Lopes, A; McManus, R; Miller, JB; Salama, JAF; Slocum, AH; Soares, V; Steiger, C; Sulkowski, MS; Tamang, SM; Thomas, DL; Traverso, G; Verma, M1
Fan, H; Gao, H; He, L; Kang, N; Liu, Y; Xu, Q; Yang, S1
Fujimura, T; Hongo, H; Inoue, S; Kosaka, T; Oya, M; Suzuki, T; Suzuki, Y; Takayama, KI1
Libre, C; Oleinikov, A; Rahman, F; Tcherniuk, S1
Carr, MJ; Ding, S; Dong, Z; Li, D; Li, J; Shi, W; Tong, Y; Wang, J; Zhang, Y; Zhang, Z; Zhuang, D1
Campagnola, G; de Los Santos, T; Diaz-San Segundo, F; Keith, A; Kloc, A; Peersen, O; Rai, DK; Rieder, E; Schafer, EA1
Carrillo-Bustamante, P; Graw, F; Guedj, J; Günther, S; Nguyen, THT; Oestereich, L1
Casas, C; Forés, J; Navarro, X; Romeo-Guitart, D1
Koraka, P; Kycko, A; Marzec, A; Orłowska, A; Osterhaus, ADME; Reichert, M; Smreczak, M; Trębas, P; Żmudziński, JF1
Furuta, Y; Gowen, BB; Hickerson, BT; Jung, KH; Komeno, T; Westover, JB1
Feldmann, H; Furuta, Y; Gowen, BB; Haddock, E; Hanley, PW; Hawman, DW; Komeno, T; Meade-White, K; Rosenke, K; Williamson, B1
Behrendt, P; Dao Thi, VL; Engelmann, M; Friesland, M; Kinast, V; Meuleman, P; Moeller, N; Praditya, D; Sayed, IM; Steinmann, E; Todt, D; Verhoye, L1
Bose, ME; Chiu, MC; Chu, H; He, J; Henrickson, KJ; Ho-Yin Wong, B; Hu, M; Huang, JD; Li, C; Luo, YS; Shuai, H; Sun, Z; Wang, D; Wang, Y; Wen, L; Yang, D; Ye, ZW; Yuan, S; Zhang, K; Zhang, X; Zhao, H; Zhao, X; Zheng, B; Zhou, J1
Abravanel, F; Cocquerel, L; Izopet, J; Meuleman, P; Montpellier, C; Sayed, IM; Verhoye, L1
Ding, CB; Hu, ZY; Jiang, JD; Peng, ZG; Qin, W; Song, DQ; Tong, JW; Zhang, JP; Zhao, LX; Zhao, Y1
Donnelly, G; Friedrich, B; Hensley, LE; Keeney, A; Lin, K; Nalca, A; Olinger, G; Reed, C; Shamblin, J; Smith, DR; Wilhelmsen, C1
Chen, Z; Li, GW; Wang, BL; Zhang, SJ1
Bruder, C; Camp, JV; Chu, YK; Chung, DH; Jonsson, CB; McAllister, R; Remold, SK; Västermark, Å1
Camp, JV; Hooper, JW; Jonsson, CB; Ogg, M1
Kwang, J; Meng, T1
Bernreuther, C; de Lamballerie, X; Emmerich, P; Günther, S; Krasemann, S; Lehmann, M; Neumann, M; Oestereich, L; Ölschläger, S; Rieger, T; Wurr, S1
Buller, RM; Spencer, JF; Tollefson, AE; Toth, K; Wold, WS; Ying, B1
Abravanel, F; Izopet, J; Kamar, N; Lhomme, S; Roque, AM1
Gao, B; He, X; Xiong, S; Zhou, L1
Kim, HJ; Wi, GR; Xu, ML1
Chen, JX; Chen, XX; Li, YL; Ma, YJ; Ning, ZY; Qi, WB; Wang, GC; Zhou, HX1
Alfson, KJ; Carrion, R; Griffiths, A; Worwa, G1
Bailey, KW; Bray, M; Dagley, A; Downs, B; Furuta, Y; Gowen, BB; Jung, KH; Sefing, EJ; Smee, DF; Van Wettere, AJ; Wandersee, L; Westover, JB1
Abravanel, F; Cocquerel, L; Debing, Y; Dubuisson, J; Farhoudi, A; Foquet, L; Izopet, J; Leroux-Roels, G; Meuleman, P; Michiels, T; Montpellier, C; Neyts, J; Sayed, IM; Verhoye, L; Wychowski, C1
Luo, HH; Wang, XH; Wu, W; Zhang, FX1
Ding, JX; Hou, YB; Li, J; Li, RR; Rong, R; Yang, Y; Zhang, CB1
Cao, P; Du, LT; Huang, JL; Ji, KM; Ji, YQ; Ma, YJ; Wu, CH; Zang, DY; Zhang, HD; Zhu, GL1
Gilgenkrantz, H; Gouttenoire, J; Mallet, V1
Bailey, KW; Furuta, Y; Gowen, BB; Hall, JO; Jung, KH; Morrey, JD; Smee, DF; Stevens, JR; Wong, MH1
Chaudhary, I; Collett, M; Douglas, D; Gao, T; Howe, AY; Immermann, F; Kneteman, NM; Lewis, J; Lund, G; Mercer, DF; O'Connell, J; Pevear, D; Speth, J; Tyrrell, DL; Villano, SA1
Bailey, KW; Hurst, BL; Morrey, JD; Smee, DF; Wong, MH1
de la Torre, JC1
Freiberg, AN; Holbrook, MR; Lee, B; Worthy, MN1
Bossart, KN; Brining, D; Broder, CC; Callison, J; Feldmann, F; Feldmann, H; Geisbert, JB; Geisbert, TW; Hickey, AC; Kercher, L; Long, D; Marzi, A; Rockx, B; Safronetz, D1
Banner, D; Fang, Y; Farooqui, A; Huang, SS; Kelvin, AA; Kelvin, DJ; Ng, DC; Rowe, T; Rubino, S1
Alonzi, D; Block, TM; Borune, N; Butters, TD; Chang, J; Goh, A; Guo, JT; Kinch, MA; Lakshminarayana, SB; Liu, B; Moriarty, R; Pan, X; Qu, X; Rayahin, JE; Reinkensmeier, G; Schul, W; Shi, PY; Wang, L; Weidner, JM; Xu, X; Yip, A; Yu, W1
Katayama, K; Miyakawa, Y; Mizui, M; Tanaka, J; Tomoguri, T; Yoshizawa, H; Yugi, H1
Aihara, Y; Fukui, H; Ikenaka, Y; Kaji, K; Noguchi, R; Shirai, Y; Yanase, K; Yoshii, J; Yoshiji, H1
Bavari, S; Bradfute, SB; Shurtleff, AC; Stuthman, KS1
Ding, CB; Jiang, JD; Peng, ZG; Song, DQ; Zhang, JP; Zhao, Y1
Kroll, JL; Weinberg, A1
Bray, M; Gowen, BB1
Dai, XY; Shen, ZH; Wang, W; Wang, ZY; Wu, QF; Ying, HZ; Yu, CH1
Kolokoltsova, OA; Linde, J; Paessler, S; Patterson, MJ; Poussard, AL; Salazar, M; Smith, JK; Smith, JN; Yun, NE1
Cao, Q; Deng, Y; Ding, C; Feng, D; Gu, B; Hu, W; Wang, J; Xie, F; Yao, K; Zhang, C; Zhang, G; Zhou, F1
Jianping, L; Liye, Z; Ruofeng, S; Xiuying, P; Xuehong, W; Yan, L1
Barnard, DL; de Jong, MD; Gross, M; Julander, JG; Nguyen, JT; Smee, DF; Went, GT1
Artiukov, AA; Kozlovskaia, ÉP; Krylova, NV; Leonova, GN; Popov, AM1
Bukh, J1
Mutimer, D1
Bleck, TP; Dietzschold, B; Ertl, HC; Fu, ZF; Jackson, AC; Leach, RP; O'Reilly, M; Rupprecht, CE; Warrell, MJ; Wilde, H; Wunner, WH1
Sidwell, RW; Smee, DF1
Medic-Mijacevic, L; Milicevic, I; Mostarica-Stojkovic, M; Pejanovic, V; Pekovic, S; Rakic, L; Stojiljkovic, M; Stosic-Grujicic, S; Subasic, S1
Appleby, TC; Hong, Z; Lau, JY; Walker, MP; Zhong, W1
Chen, WL; Chiang, BL; Chiang, DJ; Hsu, NY; Lee, YL; Ye, YL1
Bos, JC; Prins, JM; Speelman, P; van Vonderen, MG; Wertheim-van Dillen, P1
Angelova, M; Dolashka-Angelova, P; Dolashki, A; Krumova, E; Pashova, S; Serkedjieva, J; Stevanovic, S; Voelter, W; Zacharieva, S1
Blatt, LM; Day, CW; Julander, JG; Morrey, JD; Sidwell, RW; Smee, DF1
Ahmed, P; Patel, D; Taylor, D; Tyms, AS; Whitby, K1
Berry, G; Bolger, G; Dansereau, N; Klosowski, K; Lagacé, L; Lapeyre, N; Liuzzi, M; Mewhort, T1
Cramer, H; Kuang, M; Okicki, JR; Xu, Z1
Bonville, CA; Domachowske, JB; Rosenberg, HF1
Baize, S; Contamin, H; Deubel, V; Faure, C; Georges-Courbot, MC; Leyssen, P; Loth, P; Neyts, J1
Lenaerts, L; Naesens, L1
Grancher, N; Jeulin, H; Kedzierewicz, F; Le Faou, AE; Venard, V1
Hjelle, B; Hutt, J; Medina, RA; Mirowsky-Garcia, K1
Flamand, M; Liu, W; Schul, W; Vasudevan, SG; Xu, HY1
Meanwell, NA; Yeung, KS1
Bailey, K; Barnard, DL; Day, CW; Hall, TJ; Hickok, SS; Sidwell, RW; Wong, MH1
Benito, JM; Rallón, NI; Soriano, V1
Bjelobaba, I; Dacic, S; Jovanovic, S; Lavrnja, I; Mostarica-Stojkovic, M; Nedeljkovic, N; Pekovic, S; Rakic, L; Stojiljkovic, M; Stojkov, D; Stosic-Grujicic, S1
Briggiler, AM; Enria, DA; Sánchez, Z1
Monath, TP1
Hooper, J; Jonsson, CB; Mertz, G1
Gilbert, BE; McLeay, MT1
Banwatt, D; Clark, DA; Croy, BA1
Beauchamp, D; Bergeron, MG; Désormeaux, A; Dusserre, N; Gourde, P; Harvie, P; Omar, RF; Tremblay, M1
DeVincenzo, J1
Bailey, KW; Barnard, DL; Huffman, JH; Kim, CU; Morrison, A; Sidwell, RW; Syndergaard, T; Wong, MH1
Konno, K; Mori, S; Shigeta, S; Sudo, K; Watanabe, W; Yokota, T1
De Clercq, E; Gilbert, BE; Guzman, E; Matsuda, A; Minakawa, N; Moore-Poveda, DK; Neyts, J; Wyde, PR1
ter Meulen, J1
Babu, YS; Bailey, KW; Barnard, DL; Huffman, JH; Morrey, JD; Sidwell, RW; Smee, DF1
Beames, B; Brasky, KM; Chavez, D; Guerra, B; Hong, Z; Lanford, RE; Lau, JY1
Di Bisceglie, AM; McHutchison, J; Rice, CM1
Arguello, F; Greene, JF; Jayaram, HN; Yalowitz, JA1
De Clercq, E; Luczak, M1
Boyd, MR; Harris, SR1
Streissle, G1
Renis, HE1
Jacobs, JL1
Baron, S; Coppenhaver, DH; Lucia, HL1
Abelmann, WH; Crumpacker, CS; Kawai, C; Matsumori, A1
Brunette, EN; DeBruin, M; Debs, RJ; Montgomery, AB; Shanley, JD1
Blejer, JL; Nejamkis, MR; Remesar, MC; Weissenbacher, MC1
Canonico, PG1
Barrera Oro, JG; Jahrling, PB; Kenyon, RH; Liu, CT; McKee, KT; Peters, CJ1
Baron, PA; Brandt, CD; Fischer, GW; Hemming, VG; Henson, SA; Kim, HW; London, WT; Parrott, RH; Prince, GA; Rodriguez, W1

Reviews

18 review(s) available for ribavirin and Disease Models, Animal

ArticleYear
[Hepatitis E virus].
    Presse medicale (Paris, France : 1983), 2015, Volume: 44, Issue:3

    Topics: Algorithms; Animals; Antiviral Agents; Diagnosis, Differential; Disease Models, Animal; Hepatitis E; Hepatitis E virus; Humans; Ribavirin

2015
Human metapneumovirus.
    Seminars in respiratory and critical care medicine, 2011, Volume: 32, Issue:4

    Topics: Adult; Aged; Animals; Antiviral Agents; Child; Disease Models, Animal; Fluorescent Antibody Technique, Direct; Humans; Immunocompromised Host; Metapneumovirus; Paramyxoviridae Infections; Reverse Transcriptase Polymerase Chain Reaction; Ribavirin

2011
Progress in the experimental therapy of severe arenaviral infections.
    Future microbiology, 2011, Volume: 6, Issue:12

    Topics: Animals; Antibodies, Viral; Antiviral Agents; Arenaviridae Infections; Controlled Clinical Trials as Topic; Disease Models, Animal; Humans; Ribavirin; Therapies, Investigational; Treatment Outcome

2011
Animal models for the study of hepatitis C virus infection and related liver disease.
    Gastroenterology, 2012, Volume: 142, Issue:6

    Topics: Animals; Antibodies, Neutralizing; Antiviral Agents; Carcinoma, Hepatocellular; Cercopithecidae; Disease Models, Animal; Disease Susceptibility; Hepatitis Antibodies; Hepatitis C; Humans; Immunity, Innate; Interferon-alpha; Liver Diseases; Liver Neoplasms; Mice; Mice, SCID; Pan troglodytes; Platyrrhini; Ribavirin; Virus Replication

2012
Hepatitis C virus therapies: current treatments, targets and future perspectives.
    Antiviral chemistry & chemotherapy, 2003, Volume: 14, Issue:1

    Topics: Animals; Antiviral Agents; Clinical Trials as Topic; Disease Models, Animal; Drug Design; Drug Therapy, Combination; Enzyme Inhibitors; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Recombinant Proteins; Ribavirin

2003
Ribavirin in the treatment of severe acute respiratory syndrome (SARS).
    The Netherlands journal of medicine, 2003, Volume: 61, Issue:7

    Topics: Animals; Antiviral Agents; Clinical Trials as Topic; Disease Models, Animal; Humans; In Vitro Techniques; Mice; Ribavirin; Severe Acute Respiratory Syndrome

2003
Antiviral therapy for adenovirus infections.
    Antiviral research, 2006, Volume: 71, Issue:2-3

    Topics: Adenovirus Infections, Human; Adenoviruses, Human; Animals; Antiviral Agents; Cidofovir; Cytosine; Disease Models, Animal; Humans; Immunocompromised Host; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, SCID; Organophosphonates; Ribavirin

2006
Recent developments in the virology and antiviral research of severe acute respiratory syndrome coronavirus.
    Infectious disorders drug targets, 2007, Volume: 7, Issue:1

    Topics: Animals; Antibodies, Viral; Antiviral Agents; Chiroptera; Disease Models, Animal; Genome, Viral; Humans; Membrane Glycoproteins; Peptide Hydrolases; Ribavirin; RNA, Small Interfering; Severe Acute Respiratory Syndrome; Severe acute respiratory syndrome-related coronavirus; Spike Glycoprotein, Coronavirus; Viral Envelope Proteins; Viral Proteins; Viral Vaccines

2007
[Adaptive cell immune response against the hepatitis C virus infection].
    Medicina clinica, 2007, Oct-06, Volume: 129, Issue:12

    Topics: Acute Disease; Animals; Antiviral Agents; CD8-Positive T-Lymphocytes; Cells, Cultured; Disease Models, Animal; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Humans; Immunity, Cellular; Interferon-alpha; Killer Cells, Natural; Mutation; Pan troglodytes; Ribavirin; T-Lymphocytes; T-Lymphocytes, Helper-Inducer; Time Factors; Virus Replication

2007
Treatment of Argentine hemorrhagic fever.
    Antiviral research, 2008, Volume: 78, Issue:1

    Topics: Animals; Antibodies, Monoclonal; Antibodies, Viral; Arenaviruses, New World; Argentina; Clinical Trials as Topic; Disease Models, Animal; Double-Blind Method; Guinea Pigs; Hemorrhagic Fever, American; Humans; Immune Sera; Junin virus; Mice; Rats; Ribavirin

2008
Treatment of yellow fever.
    Antiviral research, 2008, Volume: 78, Issue:1

    Topics: Animals; Antiviral Agents; Cricetinae; Cytokines; Disease Models, Animal; Drug Therapy, Combination; Humans; Interferons; Ribavirin; Yellow Fever; Yellow fever virus

2008
Treatment of hantavirus pulmonary syndrome.
    Antiviral research, 2008, Volume: 78, Issue:1

    Topics: Animals; Antiviral Agents; Cricetinae; Disease Models, Animal; Hantavirus Pulmonary Syndrome; Humans; Immunotherapy; Mice; Orthohantavirus; Radiography; Rats; Ribavirin

2008
Prevention and treatment of respiratory syncytial virus infections (for advances in pediatric infectious diseases).
    Advances in pediatric infectious diseases, 1997, Volume: 13

    Topics: Adrenal Cortex Hormones; Animals; Antibodies, Monoclonal; Antiviral Agents; Bronchiolitis, Viral; Bronchodilator Agents; Bronchopulmonary Dysplasia; Cost-Benefit Analysis; Disease Models, Animal; Heart Defects, Congenital; Humans; Immunization, Passive; Immunocompromised Host; Infant; Infant, Newborn; Pneumonia, Viral; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human; Ribavirin; Vaccination

1997
Lassa fever: immuno-epidemiological approach to the study of an endemic viral haemorrhagic fever.
    Medecine tropicale : revue du Corps de sante colonial, 2000, Volume: 60, Issue:2 Suppl

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Antiviral Agents; Disease Models, Animal; Disease Vectors; Endemic Diseases; Female; Humans; Lassa Fever; Male; Middle Aged; Muridae; Ribavirin; T-Lymphocytes; Tropical Medicine

2000
New therapeutic strategies for hepatitis C.
    Hepatology (Baltimore, Md.), 2002, Volume: 35, Issue:1

    Topics: Animals; Antiviral Agents; Cell Culture Techniques; Disease Models, Animal; Drug Therapy, Combination; Enzyme Inhibitors; Hepacivirus; Hepatitis C; Humans; IMP Dehydrogenase; Interferons; Liver Diseases; Ribavirin; Virus Replication

2002
Toxicity and efficacy of benzamide riboside in cancer chemotherapy models.
    Current medicinal chemistry, 2002, Volume: 9, Issue:7

    Topics: Animals; Antineoplastic Agents; Cell Survival; Clinical Trials as Topic; Disease Models, Animal; Drug Evaluation, Preclinical; Humans; IMP Dehydrogenase; Leukemia L1210; Mice; Mice, Nude; Nucleosides; Ribavirin; Tumor Cells, Cultured

2002
Immunologic developments in AIDS--1987.
    The Year in immunology, 1989, Volume: 4

    Topics: Acquired Immunodeficiency Syndrome; Animals; Biological Factors; Clinical Trials as Topic; Colony-Stimulating Factors; Cytokines; Disease Models, Animal; Disease Susceptibility; Ethylenes; Genes, Viral; Haplorhini; Hematopoietic Stem Cells; HIV; HIV Antibodies; HIV Antigens; Humans; Mice; Receptors, HIV; Receptors, Virus; Recombinant Proteins; Retroviridae Infections; Ribavirin; Simian Immunodeficiency Virus; T-Lymphocytes; Viral Proteins

1989
Respiratory syncytial virus infections and intravenous gamma-globulins.
    The Pediatric infectious disease journal, 1988, Volume: 7, Issue:5 Suppl

    Topics: Animals; Child; Disease Models, Animal; Humans; Immunization, Passive; Immunoglobulin G; Infant; Respiratory Syncytial Viruses; Respirovirus Infections; Ribavirin

1988

Trials

4 trial(s) available for ribavirin and Disease Models, Animal

ArticleYear
HCV796: A selective nonstructural protein 5B polymerase inhibitor with potent anti-hepatitis C virus activity in vitro, in mice with chimeric human livers, and in humans infected with hepatitis C virus.
    Hepatology (Baltimore, Md.), 2009, Volume: 49, Issue:3

    Topics: Animals; Antiviral Agents; Benzofurans; Disease Models, Animal; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Enzyme Inhibitors; Hepacivirus; Hepatitis C; Hepatocytes; Humans; Interferon alpha-2; Interferon-alpha; Liver; Mice; Mice, SCID; Polyethylene Glycols; Recombinant Proteins; Replicon; Ribavirin; Sulfonamides; Viral Nonstructural Proteins

2009
Immunologic developments in AIDS--1987.
    The Year in immunology, 1989, Volume: 4

    Topics: Acquired Immunodeficiency Syndrome; Animals; Biological Factors; Clinical Trials as Topic; Colony-Stimulating Factors; Cytokines; Disease Models, Animal; Disease Susceptibility; Ethylenes; Genes, Viral; Haplorhini; Hematopoietic Stem Cells; HIV; HIV Antibodies; HIV Antigens; Humans; Mice; Receptors, HIV; Receptors, Virus; Recombinant Proteins; Retroviridae Infections; Ribavirin; Simian Immunodeficiency Virus; T-Lymphocytes; Viral Proteins

1989
Efficacy, toxicology and clinical applications of ribavirin against virulent RNA viral infections.
    Antiviral research, 1985, Volume: Suppl 1

    Topics: Administration, Oral; Animals; Arbovirus Infections; Arenaviridae; Arenaviridae Infections; Cattle; Clinical Trials as Topic; Cricetinae; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Encephalitis; Erythrocytes; Hemorrhagic Fever with Renal Syndrome; Hepatitis, Viral, Animal; Humans; Macaca mulatta; Mice; Orthohantavirus; Ribavirin; Ribonucleosides; Rift Valley Fever; Rift Valley fever virus; RNA Viruses; Virus Diseases

1985
Respiratory syncytial virus infections and intravenous gamma-globulins.
    The Pediatric infectious disease journal, 1988, Volume: 7, Issue:5 Suppl

    Topics: Animals; Child; Disease Models, Animal; Humans; Immunization, Passive; Immunoglobulin G; Infant; Respiratory Syncytial Viruses; Respirovirus Infections; Ribavirin

1988

Other Studies

95 other study(ies) available for ribavirin and Disease Models, Animal

ArticleYear
Activity of T-1106 in a hamster model of yellow Fever virus infection.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:6

    Topics: Amides; Animals; Antiviral Agents; Chlorocebus aethiops; Cricetinae; Disease Models, Animal; Female; Humans; Mesocricetus; Pyrazines; Treatment Outcome; Vero Cells; Yellow Fever; Yellow fever virus

2007
Synthesis and anti-influenza activities of carboxyl alkoxyalkyl esters of 4-guanidino-Neu5Ac2en (zanamivir).
    Bioorganic & medicinal chemistry letters, 2007, Sep-01, Volume: 17, Issue:17

    Topics: Administration, Oral; Animals; Cell Line; Disease Models, Animal; Dogs; Drug Design; Humans; Influenza A virus; Influenza Vaccines; Influenza, Human; Infusions, Parenteral; Inhibitory Concentration 50; Mice; Ribavirin; Zanamivir

2007
Discovery and optimization of potent broad-spectrum arenavirus inhibitors derived from benzimidazole.
    Bioorganic & medicinal chemistry letters, 2013, Feb-01, Volume: 23, Issue:3

    Topics: Animals; Antiviral Agents; Arenavirus; Benzimidazoles; Disease Models, Animal; Drug Discovery; Guinea Pigs; Small Molecule Libraries

2013
Synthesis and anti-BVDV activity of novel δ-sultones in vitro: implications for HCV therapies.
    Bioorganic & medicinal chemistry letters, 2014, May-15, Volume: 24, Issue:10

    Topics: Animals; Antiviral Agents; Cattle; Diarrhea Viruses, Bovine Viral; Disease Models, Animal; Drug Design; Hepacivirus

2014
Inhibition of natriuretic peptide receptor 1 reduces itch in mice.
    Science translational medicine, 2019, 07-10, Volume: 11, Issue:500

    Topics: Animals; Behavior, Animal; Cell-Free System; Dermatitis, Contact; Disease Models, Animal; Ganglia, Spinal; Humans; Mice, Inbred C57BL; Mice, Knockout; Neurons; Pruritus; Receptors, Atrial Natriuretic Factor; Reproducibility of Results; Signal Transduction; Small Molecule Libraries

2019
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
    Proceedings of the National Academy of Sciences of the United States of America, 2020, 12-08, Volume: 117, Issue:49

    Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection

2020
Susceptibility of Type I Interferon Receptor Knock-Out Mice to Heartland Bandavirus (HRTV) Infection and Efficacy of Favipiravir and Ribavirin in the Treatment of the Mice Infected with HRTV.
    Viruses, 2022, 07-28, Volume: 14, Issue:8

    Topics: Amides; Animals; Disease Models, Animal; Humans; Mice; Mice, Knockout; Phlebovirus; Pyrazines; Receptor, Interferon alpha-beta; Ribavirin; Solvents; Thrombocytopenia

2022
Cellular Signaling Analysis shows antiviral, ribavirin-mediated ribosomal signaling modulation.
    Antiviral research, 2019, Volume: 171

    Topics: Animals; Antiviral Agents; Biomarkers; Cell Line; Cytokines; Disease Models, Animal; Drug Discovery; Herpes Simplex; Herpesvirus 1, Human; Host-Pathogen Interactions; Humans; Mice; Ribavirin; Ribosomal Protein S6 Kinases; Ribosomes; Signal Transduction; STAT1 Transcription Factor; Virus Replication

2019
Gut DNA Virome Diversity and Its Association with Host Bacteria Regulate Inflammatory Phenotype and Neuronal Immunotoxicity in Experimental Gulf War Illness.
    Viruses, 2019, 10-21, Volume: 11, Issue:10

    Topics: Animals; Antiviral Agents; Bacteria; Cytokines; Disease Models, Animal; DNA; Dysbiosis; Gastrointestinal Microbiome; Immunity, Innate; Inflammation; Male; Mice; Mice, Inbred C57BL; Neurons; Permethrin; Persian Gulf Syndrome; Phenotype; Pyridostigmine Bromide; Ribavirin; Viruses

2019
A Lassa Fever Live-Attenuated Vaccine Based on Codon Deoptimization of the Viral Glycoprotein Gene.
    mBio, 2020, 02-25, Volume: 11, Issue:1

    Topics: A549 Cells; Africa, Western; Amino Acid Sequence; Animals; Arenaviridae; Arenavirus; Bunyaviridae; Chlorocebus aethiops; Codon; Disease Models, Animal; Female; Genes, Viral; Genome, Viral; Glycoproteins; Guinea Pigs; Humans; Lassa Fever; Lassa virus; Male; Ribavirin; Vaccines, Attenuated; Vero Cells; Viral Vaccines

2020
Ribavirin does not potentiate favipiravir antiviral activity against Ebola virus in non-human primates.
    Antiviral research, 2020, Volume: 177

    Topics: Amides; Animals; Antiviral Agents; Disease Models, Animal; Ebolavirus; Female; Hemorrhagic Fever, Ebola; Macaca fascicularis; Pyrazines; Ribavirin; Viral Load; Virus Replication

2020
Clinical Management of Argentine Hemorrhagic Fever using Ribavirin and Favipiravir, Belgium, 2020.
    Emerging infectious diseases, 2020, Volume: 26, Issue:7

    Topics: Amides; Animals; Belgium; Disease Models, Animal; Female; Humans; Junin virus; Pyrazines; Ribavirin

2020
Development of a long-acting direct-acting antiviral system for hepatitis C virus treatment in swine.
    Proceedings of the National Academy of Sciences of the United States of America, 2020, 06-02, Volume: 117, Issue:22

    Topics: Animals; Antiviral Agents; Benzimidazoles; Carbamates; Cost-Benefit Analysis; Disease Models, Animal; Drug Carriers; Drug Delivery Systems; Fluorenes; Hepacivirus; Hepatitis C, Chronic; Imidazoles; Liver Cirrhosis; Models, Animal; Pyrrolidines; Ribavirin; Sofosbuvir; Swine; Valine

2020
Ginsenoside Rb1 is an immune-stimulatory agent with antiviral activity against enterovirus 71.
    Journal of ethnopharmacology, 2021, Feb-10, Volume: 266

    Topics: Adjuvants, Immunologic; Animals; Antiviral Agents; Cell Line, Tumor; Disease Models, Animal; Dose-Response Relationship, Drug; Enterovirus A, Human; Enterovirus Infections; Ginsenosides; Humans; Mice; Mice, Inbred ICR; Panax; Rhabdomyosarcoma; Ribavirin

2021
Subtype-specific collaborative transcription factor networks are promoted by OCT4 in the progression of prostate cancer.
    Nature communications, 2021, 06-18, Volume: 12, Issue:1

    Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Drug Resistance, Neoplasm; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; HEK293 Cells; Hepatocyte Nuclear Factor 3-alpha; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Nuclear Respiratory Factor 1; Octamer Transcription Factor-3; Prostatic Neoplasms, Castration-Resistant; Receptors, Androgen; Ribavirin; Signal Transduction; Transcriptome

2021
Chloroquine and pyrimethamine inhibit the replication of human respiratory syncytial virus A.
    The Journal of general virology, 2021, Volume: 102, Issue:8

    Topics: Animals; Antiviral Agents; Cell Line; Cell Survival; Chloroquine; Disease Models, Animal; Female; Humans; Immunocompromised Host; Mice; Mice, Inbred BALB C; Pyrimethamine; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human; Ribavirin; Virus Replication

2021
Protective Efficacies of Formaldehyde-Inactivated Whole-Virus Vaccine and Antivirals in a Murine Model of Coxsackievirus A10 Infection.
    Journal of virology, 2017, 07-01, Volume: 91, Issue:13

    Topics: Animals; Antibodies, Neutralizing; Antibodies, Viral; Antiviral Agents; Coxsackievirus Infections; Disease Models, Animal; Enterovirus; Immunity, Maternally-Acquired; Immunization, Passive; Injections, Intramuscular; Interferon-gamma; Mice, Inbred ICR; Ribavirin; Treatment Outcome; Vaccines, Inactivated; Viral Vaccines; Virus Replication

2017
Attenuation of Foot-and-Mouth Disease Virus by Engineered Viral Polymerase Fidelity.
    Journal of virology, 2017, 08-01, Volume: 91, Issue:15

    Topics: Amino Acid Substitution; Animals; Antigens, Viral; Antiviral Agents; Cells, Cultured; Cricetinae; Disease Models, Animal; DNA Mutational Analysis; Drug Resistance, Viral; Fluorouracil; Foot-and-Mouth Disease; Foot-and-Mouth Disease Virus; Mice; Mutagenesis, Site-Directed; Point Mutation; Protein Engineering; Ribavirin; Swine; Tryptophan; Viral Nonstructural Proteins; Viral Plaque Assay

2017
Determining Ribavirin's mechanism of action against Lassa virus infection.
    Scientific reports, 2017, 09-15, Volume: 7, Issue:1

    Topics: Amides; Animals; Antiviral Agents; Disease Models, Animal; Drug Therapy, Combination; Lassa Fever; Lassa virus; Mice, Inbred C57BL; Models, Theoretical; Pyrazines; Ribavirin; Treatment Outcome; Viral Load

2017
Boosted Regeneration and Reduced Denervated Muscle Atrophy by NeuroHeal in a Pre-clinical Model of Lumbar Root Avulsion with Delayed Reimplantation.
    Scientific reports, 2017, 09-20, Volume: 7, Issue:1

    Topics: Acamprosate; Animals; Disease Models, Animal; Drug Combinations; Female; Lumbar Vertebrae; Muscle Denervation; Muscle, Skeletal; Muscular Atrophy; Nerve Regeneration; Neuroprotective Agents; Radiculopathy; Rats, Sprague-Dawley; Recovery of Function; Replantation; Ribavirin; Spinal Nerve Roots

2017
The effect of combined drugs therapy on the course of clinical rabies infection in a murine model.
    Vaccine, 2019, 08-02, Volume: 37, Issue:33

    Topics: Amides; Animals; Antibodies, Viral; Antiviral Agents; Disease Models, Animal; Drug Therapy, Combination; Female; Immunity, Innate; Mice; Mice, Inbred C57BL; Pyrazines; Rabies; Rabies virus; Ribavirin; Serpins; Viral Proteins; Virus Replication

2019
Effective Treatment of Experimental Lymphocytic Choriomeningitis Virus Infection: Consideration of Favipiravir for Use With Infected Organ Transplant Recipients.
    The Journal of infectious diseases, 2018, 07-13, Volume: 218, Issue:4

    Topics: Amides; Animals; Antiviral Agents; Disease Models, Animal; Female; Immunocompromised Host; Lymphocytic Choriomeningitis; Lymphocytic choriomeningitis virus; Male; Mice, Inbred NZB; Pyrazines; Ribavirin; Survival Analysis; Transplant Recipients; Treatment Outcome; Viral Load

2018
Favipiravir (T-705) but not ribavirin is effective against two distinct strains of Crimean-Congo hemorrhagic fever virus in mice.
    Antiviral research, 2018, Volume: 157

    Topics: Amides; Animals; Antiviral Agents; Disease Models, Animal; Hemorrhagic Fever Virus, Crimean-Congo; Hemorrhagic Fever, Crimean; Mice; Pyrazines; Ribavirin; RNA, Viral; Survival Analysis; Treatment Outcome; Viral Load

2018
The natural compound silvestrol inhibits hepatitis E virus (HEV) replication in vitro and in vivo.
    Antiviral research, 2018, Volume: 157

    Topics: Aglaia; Animals; Antiviral Agents; Cells, Cultured; Disease Models, Animal; Drug Interactions; Feces; Hepatitis E; Hepatitis E virus; Humans; Mice; Ribavirin; Triterpenes; Viral Load; Virus Replication

2018
Establishment of a lethal aged mouse model of human respiratory syncytial virus infection.
    Antiviral research, 2019, Volume: 161

    Topics: Aging; Animals; Antiviral Agents; Cell Line; Cyclophosphamide; Disease Models, Animal; Genome, Viral; Humans; Lung; Mice; Mice, Inbred BALB C; Mutation; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human; Ribavirin; Virus Replication

2019
Hepatitis E Virus (HEV) Open Reading Frame 2 Antigen Kinetics in Human-Liver Chimeric Mice and Its Impact on HEV Diagnosis.
    The Journal of infectious diseases, 2019, 07-31, Volume: 220, Issue:5

    Topics: Animals; Disease Models, Animal; Feces; Hepatitis Antigens; Hepatitis E; Hepatitis E virus; Humans; Kinetics; Liver; Mice; Mice, SCID; Ribavirin; RNA, Viral; Viral Proteins

2019
HCV IRES-mediated core expression in zebrafish.
    PloS one, 2013, Volume: 8, Issue:3

    Topics: Animals; Antiviral Agents; Biomarkers; Disease Models, Animal; Dose-Response Relationship, Drug; Gene Expression Regulation, Viral; Genes, Reporter; Green Fluorescent Proteins; Hepacivirus; Hepatitis C; Host-Pathogen Interactions; Humans; Interferon alpha-2; Interferon-alpha; Larva; Liver; Mutant Chimeric Proteins; Recombinant Proteins; Ribavirin; RNA, Messenger; Viral Core Proteins; Vitamin B 12; Zebrafish

2013
Aerosol exposure to Rift Valley fever virus causes earlier and more severe neuropathology in the murine model, which has important implications for therapeutic development.
    PLoS neglected tropical diseases, 2013, Volume: 7, Issue:4

    Topics: Animals; Antiviral Agents; Disease Models, Animal; Female; Mice; Mice, Inbred BALB C; Peripheral Nervous System Diseases; Ribavirin; Rift Valley Fever; Rift Valley fever virus; Viral Vaccines

2013
Effect of the Haoqinqingdan decoction on damp-heat syndrome in rats with influenza viral pneumonia.
    Asian Pacific journal of tropical medicine, 2013, Volume: 6, Issue:8

    Topics: Animals; Antiviral Agents; Body Temperature; Body Weight; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Fever; Flow Cytometry; Immunologic Factors; Interferon-gamma; Interleukin-4; Lymphocyte Subsets; Orthomyxoviridae Infections; Plant Extracts; Plants, Medicinal; Pneumonia, Viral; Rats; Rats, Wistar; Ribavirin; Treatment Outcome

2013
The murine model for Hantaan virus-induced lethal disease shows two distinct paths in viral evolutionary trajectory with and without ribavirin treatment.
    Journal of virology, 2013, Volume: 87, Issue:20

    Topics: Animals; Animals, Newborn; Antiviral Agents; Disease Models, Animal; DNA Mutational Analysis; Evolution, Molecular; Female; Hantaan virus; Hemorrhagic Fever with Renal Syndrome; Lung; Mice; Mice, Inbred ICR; Mutation Rate; Pregnancy; Ribavirin; RNA, Viral; Sequence Analysis, DNA; Viral Load

2013
Ribavirin protects Syrian hamsters against lethal hantavirus pulmonary syndrome--after intranasal exposure to Andes virus.
    Viruses, 2013, Nov-08, Volume: 5, Issue:11

    Topics: Animals; Antiviral Agents; Cricetinae; Disease Models, Animal; Female; Hantavirus Pulmonary Syndrome; Humans; Mesocricetus; Nasal Cavity; Orthohantavirus; Ribavirin

2013
Attenuation of human enterovirus 71 high-replication-fidelity variants in AG129 mice.
    Journal of virology, 2014, Volume: 88, Issue:10

    Topics: Animals; Antiviral Agents; Cell Line; Disease Models, Animal; Drug Resistance, Viral; Enterovirus A, Human; Enterovirus Infections; Humans; Lethal Dose 50; Mice; Models, Molecular; Mutant Proteins; Mutation, Missense; Protein Conformation; Ribavirin; RNA-Dependent RNA Polymerase; Serial Passage; Survival Analysis; Virulence

2014
Evaluation of antiviral efficacy of ribavirin, arbidol, and T-705 (favipiravir) in a mouse model for Crimean-Congo hemorrhagic fever.
    PLoS neglected tropical diseases, 2014, Volume: 8, Issue:5

    Topics: Amides; Animals; Antiviral Agents; Chlorocebus aethiops; Disease Models, Animal; Female; Hemorrhagic Fever Virus, Crimean-Congo; Hemorrhagic Fever, Crimean; Indoles; Liver; Male; Mice; Mice, Transgenic; Pyrazines; Receptor, Interferon alpha-beta; Ribavirin; Vero Cells

2014
Cidofovir and brincidofovir reduce the pathology caused by systemic infection with human type 5 adenovirus in immunosuppressed Syrian hamsters, while ribavirin is largely ineffective in this model.
    Antiviral research, 2014, Volume: 112

    Topics: Adenoviridae Infections; Adenoviruses, Human; Alanine Transaminase; Animals; Body Weight; Cell Line; Cidofovir; Cytosine; Disease Models, Animal; Female; Humans; Immunocompromised Host; Liver; Mesocricetus; Organophosphonates; Ribavirin; Survival Analysis; Treatment Outcome; Viral Load

2014
Inhibition of Histone Deacetylase Activity Aggravates Coxsackievirus B3-Induced Myocarditis by Promoting Viral Replication and Myocardial Apoptosis.
    Journal of virology, 2015, Volume: 89, Issue:20

    Topics: Androstadienes; Animals; Antiviral Agents; Apoptosis; Autophagy-Related Protein 5; Coxsackievirus Infections; Disease Models, Animal; Enterovirus B, Human; Gene Expression Regulation; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Hydroxamic Acids; Male; Mice; Mice, Inbred BALB C; Microtubule-Associated Proteins; Myocarditis; Myocardium; Phagosomes; Ribavirin; RNA, Small Interfering; Virus Replication; Vorinostat; Wortmannin

2015
The effect of dietary bovine colostrum on respiratory syncytial virus infection and immune responses following the infection in the mouse.
    Journal of microbiology (Seoul, Korea), 2015, Volume: 53, Issue:9

    Topics: Animals; Antibodies, Viral; Cattle; CD8-Positive T-Lymphocytes; Colostrum; Diet; Disease Models, Animal; Female; Humans; Lung; Mice, Inbred BALB C; Pregnancy; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human; Ribavirin; Viral Load

2015
[Antiviral effects of the combination of glycyrrhizin and ribavirin against influenza A H1N1 virus infection in vivo].
    Yao xue xue bao = Acta pharmaceutica Sinica, 2015, Volume: 50, Issue:8

    Topics: Animals; Antiviral Agents; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Glycyrrhizic Acid; Inflammation; Influenza A Virus, H1N1 Subtype; Interleukin-1beta; Interleukin-6; Lung; Mice; Orthomyxoviridae Infections; Pneumonia, Viral; Ribavirin; Tumor Necrosis Factor-alpha

2015
Determination and Therapeutic Exploitation of Ebola Virus Spontaneous Mutation Frequency.
    Journal of virology, 2015, Dec-16, Volume: 90, Issue:5

    Topics: Animals; Antiviral Agents; Disease Models, Animal; Ebolavirus; Female; Genes, Reporter; Genetic Variation; Green Fluorescent Proteins; Hemorrhagic Fever, Ebola; High-Throughput Nucleotide Sequencing; Humans; Inhibitory Concentration 50; Macaca fascicularis; Male; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mutation Rate; Ribavirin; RNA, Viral; Sequence Analysis, DNA; Survival Analysis; Treatment Outcome

2015
Low-dose ribavirin potentiates the antiviral activity of favipiravir against hemorrhagic fever viruses.
    Antiviral research, 2016, Volume: 126

    Topics: Amides; Animals; Antiviral Agents; Arenavirus; Chlorocebus aethiops; Cricetinae; Dengue Virus; Disease Models, Animal; Drug Synergism; Female; Guinea Pigs; Hemorrhagic Fever Virus, Crimean-Congo; Hemorrhagic Fever, American; Hemorrhagic Fever, Ebola; Hemorrhagic Fevers, Viral; Junin virus; Male; Mesocricetus; Mice; Orthohantavirus; Pyrazines; Ribavirin; RNA Viruses; Vero Cells

2016
Study of hepatitis E virus infection of genotype 1 and 3 in mice with humanised liver.
    Gut, 2017, Volume: 66, Issue:5

    Topics: Animals; Antiviral Agents; Disease Models, Animal; Gene Expression; Genotype; Hepatitis E; Hepatitis E virus; Hepatocytes; Host-Pathogen Interactions; Humans; Liver; Mice; Ribavirin; RNA, Viral; Transplantation Chimera; Viral Load; Viral Proteins

2017
Haoqin Qingdan Decoction () and ribavirin therapy downregulate CD14 and toll-like receptor 4 in febrile disease with dampness-heat syndrome in a mouse model.
    Chinese journal of integrative medicine, 2016, Volume: 22, Issue:10

    Topics: Animals; Behavior, Animal; Disease Models, Animal; Down-Regulation; Drugs, Chinese Herbal; Fever; Gene Expression Profiling; Lipopolysaccharide Receptors; Lung; Mice, Inbred BALB C; Ribavirin; Syndrome; Toll-Like Receptor 4

2016
Mahuang-Xixin-Fuzi decoction reduces the infection of influenza A virus in Kidney-Yang deficiency syndrome mice.
    Journal of ethnopharmacology, 2016, Nov-04, Volume: 192

    Topics: Administration, Oral; Animals; Antioxidants; Antiviral Agents; Chemokine CCL2; Disease Models, Animal; Drugs, Chinese Herbal; Estradiol; Inflammation Mediators; Influenza A Virus, H1N1 Subtype; Interleukin-6; Kidney Diseases; Lung; Malondialdehyde; Mice; Orthomyxoviridae Infections; Pulmonary Edema; Ribavirin; Superoxide Dismutase; Time Factors; Tumor Necrosis Factor-alpha; Yang Deficiency

2016
Rapid CO breath test screening of drugs for protective effects on ribavirin-induced hemolysis in a rabbit model: a pilot study.
    Journal of breath research, 2016, 08-10, Volume: 10, Issue:3

    Topics: Anemia, Hemolytic; Animals; Antiviral Agents; Breath Tests; Carbon Monoxide; Disease Models, Animal; Drug Evaluation, Preclinical; Erythrocyte Count; Erythrocytes; Female; Glutathione; Hemoglobins; Male; Pilot Projects; Protective Agents; Rabbits; Ribavirin

2016
[A murine model for an ignored chronic infection: hepatitis E !]
    Medecine sciences : M/S, 2016, Volume: 32, Issue:10

    Topics: Animals; Chronic Disease; Disease Models, Animal; Hepatitis E; Hepatocytes; Heterografts; Humans; Mice; Mice, Inbred NOD; Mice, SCID; Mice, Transgenic; Ribavirin; Urokinase-Type Plasminogen Activator

2016
Treatment of late stage disease in a model of arenaviral hemorrhagic fever: T-705 efficacy and reduced toxicity suggests an alternative to ribavirin.
    PloS one, 2008, Volume: 3, Issue:11

    Topics: Absorption; Administration, Oral; Alanine Transaminase; Amides; Animals; Arenaviridae Infections; Aspartate Aminotransferases; Cricetinae; Disease Models, Animal; Disease Progression; Female; Hemorrhagic Fevers, Viral; Interferon Type I; Liver Diseases; Mesocricetus; Pichinde virus; Pyrazines; Ribavirin; Survival Analysis; Treatment Outcome; Viral Load

2008
Effects of double combinations of amantadine, oseltamivir, and ribavirin on influenza A (H5N1) virus infections in cell culture and in mice.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:5

    Topics: Amantadine; Animals; Antiviral Agents; Cell Line; Disease Models, Animal; Drug Interactions; Drug Resistance, Viral; Drug Therapy, Combination; Humans; Influenza A Virus, H5N1 Subtype; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Orthomyxoviridae Infections; Oseltamivir; Ribavirin; Specific Pathogen-Free Organisms; Treatment Outcome

2009
Molecular and cell biology of the prototypic arenavirus LCMV: implications for understanding and combating hemorrhagic fever arenaviruses.
    Annals of the New York Academy of Sciences, 2009, Volume: 1171 Suppl 1

    Topics: Animals; Antiviral Agents; Arenaviridae; Arenaviridae Infections; Bioterrorism; Disease Models, Animal; Genome, Viral; Humans; Lassa Fever; Lassa virus; Lymphocytic Choriomeningitis; Lymphocytic choriomeningitis virus; Ribavirin; RNA, Viral; United States; Viral Vaccines

2009
Combined chloroquine and ribavirin treatment does not prevent death in a hamster model of Nipah and Hendra virus infection.
    The Journal of general virology, 2010, Volume: 91, Issue:Pt 3

    Topics: Animals; Antiviral Agents; Chloroquine; Cricetinae; Disease Models, Animal; Drug Therapy, Combination; Hendra Virus; Henipavirus Infections; Humans; Mesocricetus; Nipah Virus; Ribavirin; Survival Analysis; Treatment Outcome

2010
A novel model of lethal Hendra virus infection in African green monkeys and the effectiveness of ribavirin treatment.
    Journal of virology, 2010, Volume: 84, Issue:19

    Topics: Animals; Antiviral Agents; Base Sequence; Brain; Chlorocebus aethiops; Disease Models, Animal; DNA Primers; DNA, Viral; Female; Hendra Virus; Henipavirus Infections; Humans; Lung; Male; Radiography; Ribavirin; Virus Replication

2010
In vivo ribavirin activity against severe pandemic H1N1 Influenza A/Mexico/4108/2009.
    The Journal of general virology, 2010, Volume: 91, Issue:Pt 12

    Topics: Animals; Antiviral Agents; Chick Embryo; Disease Models, Animal; Disease Progression; Female; Influenza A Virus, H1N1 Subtype; Lung; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Microbial Sensitivity Tests; Orthomyxoviridae Infections; Ribavirin; Survival Analysis

2010
Combination of α-glucosidase inhibitor and ribavirin for the treatment of dengue virus infection in vitro and in vivo.
    Antiviral research, 2011, Volume: 89, Issue:1

    Topics: Administration, Oral; Animals; Antiviral Agents; Cell Line; Dengue; Dengue Virus; Disease Models, Animal; Drug Therapy, Combination; Enzyme Inhibitors; Female; Glycoside Hydrolase Inhibitors; Humans; Inhibitory Concentration 50; Mice; Ribavirin; Viremia

2011
Interferon alone or combined with ribavirin for acute prolonged infection with hepatitis C virus in chimpanzees.
    Intervirology, 2011, Volume: 54, Issue:4

    Topics: Animals; Disease Models, Animal; Drug Therapy, Combination; Hepatitis C; Interferon-alpha; Pan troglodytes; Primate Diseases; Ribavirin; RNA, Viral; Serum; Treatment Outcome

2011
Cocktail therapy with a combination of interferon, ribavirin and angiotensin-II type 1 receptor blocker attenuates murine liver fibrosis development.
    International journal of molecular medicine, 2011, Volume: 28, Issue:1

    Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Disease Models, Animal; Drug Therapy, Combination; Hepatic Stellate Cells; Interferons; Liver Cirrhosis; Male; Mice; Mice, Inbred BALB C; Rats; Ribavirin; Vascular Endothelial Growth Factor A

2011
A STAT-1 knockout mouse model for Machupo virus pathogenesis.
    Virology journal, 2011, Jun-14, Volume: 8

    Topics: Animals; Antiviral Agents; Arenaviridae Infections; Arenaviruses, New World; Disease Models, Animal; Female; Humans; Male; Mice; Mice, Knockout; Ribavirin; STAT1 Transcription Factor; Survival Analysis; Treatment Outcome; Virus Replication

2011
Zebrafish as a potential model organism for drug test against hepatitis C virus.
    PloS one, 2011, Volume: 6, Issue:8

    Topics: Alkaloids; Animals; Antiviral Agents; Blotting, Western; Disease Models, Animal; Drug Evaluation, Preclinical; Fish Diseases; Gene Amplification; Gene Expression Regulation, Viral; Genetic Vectors; Green Fluorescent Proteins; Hepacivirus; Hepatitis C; Hepatocytes; Humans; In Situ Hybridization; Larva; Microinjections; Microscopy, Fluorescence; Quinolizines; Replicon; Reverse Transcriptase Polymerase Chain Reaction; Ribavirin; Untranslated Regions; Viral Nonstructural Proteins; Zebrafish

2011
Chemical compositions and anti-influenza activities of essential oils from Mosla dianthera.
    Journal of ethnopharmacology, 2012, Jan-31, Volume: 139, Issue:2

    Topics: Animals; Antiviral Agents; Colorimetry; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Gas Chromatography-Mass Spectrometry; Glutathione Peroxidase; Inflammation Mediators; Influenza A Virus, H1N1 Subtype; Interferon-gamma; Interleukin-4; Lamiaceae; Lung; Malondialdehyde; Mice; Mice, Inbred ICR; Oils, Volatile; Orthomyxoviridae Infections; Plant Components, Aerial; Plant Oils; Plants, Medicinal; Ribavirin; Superoxide Dismutase; Virus Replication

2012
Effect of ribavirin on junin virus infection in guinea pigs.
    Zoonoses and public health, 2012, Volume: 59, Issue:4

    Topics: Animals; Antiviral Agents; Arenaviridae Infections; Chlorocebus aethiops; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Guinea Pigs; Junin virus; Kaplan-Meier Estimate; Post-Exposure Prophylaxis; Ribavirin; Vero Cells

2012
In vitro and in vivo evaluation of ribavirin and pleconaril antiviral activity against enterovirus 71 infection.
    Archives of virology, 2012, Volume: 157, Issue:4

    Topics: Animals; Animals, Newborn; Antiviral Agents; Cell Line, Tumor; Cell Survival; Child, Preschool; Disease Models, Animal; Enterovirus A, Human; Enterovirus Infections; Humans; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Oxadiazoles; Oxazoles; Ribavirin; Survival Analysis

2012
Therapeutic efficacy of Hypericum perforatum L. extract for mice infected with an influenza A virus.
    Canadian journal of physiology and pharmacology, 2012, Volume: 90, Issue:2

    Topics: Animals; Antiviral Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Female; Hypericum; Inflammation Mediators; Influenza A virus; Interferon-gamma; Interleukin-10; Interleukin-6; Lung; Male; Mice; Mice, Inbred BALB C; Orthomyxoviridae Infections; Ribavirin; Time Factors; Tumor Necrosis Factor-alpha; Viral Load

2012
Efficacy of combined therapy with amantadine, oseltamivir, and ribavirin in vivo against susceptible and amantadine-resistant influenza A viruses.
    PloS one, 2012, Volume: 7, Issue:1

    Topics: Amantadine; Animals; Antiviral Agents; Cells, Cultured; Disease Models, Animal; Dogs; Drug Combinations; Drug Resistance, Viral; Drug Synergism; Female; Influenza A Virus, H5N1 Subtype; Mice; Mice, Inbred BALB C; Orthomyxoviridae Infections; Oseltamivir; Placebos; Ribavirin; Treatment Outcome

2012
[Investigation of luromarin efficacy on mice with experimental tick-borne encephalitis].
    Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 2011, Volume: 56, Issue:7-8

    Topics: Acridines; Animals; Antiviral Agents; Caffeic Acids; Disease Models, Animal; Drug Therapy, Combination; Encephalitis Viruses, Tick-Borne; Encephalitis, Tick-Borne; Luteolin; Mice; Ribavirin; Rosmarinic Acid; Virus Replication; Zosteraceae

2011
Understanding the switchbacks: the impact of direct antivirals on the minimization of hepatitis C virus recurrence after transplantation.
    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2012, Volume: 18 Suppl 2

    Topics: Animals; Antiviral Agents; Disease Models, Animal; Drug Interactions; Drug Therapy, Combination; Hepacivirus; Hepatitis C; Hepatitis C Antibodies; Humans; Interferons; Liver Transplantation; Mice; Ribavirin; Secondary Prevention

2012
Management of rabies in humans.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2003, Jan-01, Volume: 36, Issue:1

    Topics: Adrenal Cortex Hormones; Animals; Antibodies, Monoclonal; Antibodies, Viral; Combined Modality Therapy; Disease Models, Animal; Humans; Interferon-alpha; Ketamine; Mice; Palliative Care; Rabies; Rabies Vaccines; Ribavirin

2003
Viruses of the Bunya- and Togaviridae families: potential as bioterrorism agents and means of control.
    Antiviral research, 2003, Volume: 57, Issue:1-2

    Topics: Alphavirus; Alphavirus Infections; Animals; Antiviral Agents; Bioterrorism; Bunyaviridae; Bunyaviridae Infections; Cricetinae; Disease Models, Animal; Guinea Pigs; Humans; Interferon-alpha; Mice; Ribavirin; Viral Vaccines

2003
Ribavirin reduces clinical signs and pathological changes of experimental autoimmune encephalomyelitis in Dark Agouti rats.
    Journal of neuroscience research, 2003, Apr-15, Volume: 72, Issue:2

    Topics: Adjuvants, Immunologic; Animals; Demyelinating Diseases; Disease Models, Animal; Disease Susceptibility; Encephalomyelitis, Autoimmune, Experimental; Female; Immunosuppressive Agents; Macrophages; Microglia; Neuroprotective Agents; Rats; Rats, Inbred Strains; Ribavirin; Spinal Cord

2003
Ribavirin or CpG DNA sequence-modulated dendritic cells decrease the IgE level and airway inflammation.
    American journal of respiratory and critical care medicine, 2003, Sep-01, Volume: 168, Issue:5

    Topics: Adjuvants, Immunologic; Animals; Antiviral Agents; Asthma; Base Sequence; Dendritic Cells; Disease Models, Animal; Female; Immunoglobulin E; Immunotherapy; In Vitro Techniques; Mice; Mice, Inbred BALB C; Oligodeoxyribonucleotides; Ribavirin

2003
Structural and functional analysis of glycosylated Cu/Zn-superoxide dismutase from the fungal strain Humicola lutea 103.
    Biochemical and biophysical research communications, 2004, May-14, Volume: 317, Issue:4

    Topics: Amino Acid Sequence; Animals; Ascomycota; Biomass; Cattle; Circular Dichroism; Copper; Disease Models, Animal; Female; Glycosylation; Influenza A virus; Isoenzymes; Male; Mice; Mice, Inbred ICR; Molecular Sequence Data; Orthomyxoviridae Infections; Protein Subunits; Ribavirin; Sequence Alignment; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Structure-Activity Relationship; Superoxide Dismutase; Trypsin

2004
Effect of interferon-alpha and interferon-inducers on West Nile virus in mouse and hamster animal models.
    Antiviral chemistry & chemotherapy, 2004, Volume: 15, Issue:2

    Topics: Aminoquinolines; Animals; Cells, Cultured; Cricetinae; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Imiquimod; Interferon Inducers; Interferon Type I; Interferon-alpha; Interferons; Mice; Mice, Inbred BALB C; Motor Activity; Poly I-C; Poly U; Recombinant Proteins; Ribavirin; Survival Rate; Time Factors; West Nile Fever; West Nile virus

2004
Action of celgosivir (6 O-butanoyl castanospermine) against the pestivirus BVDV: implications for the treatment of hepatitis C.
    Antiviral chemistry & chemotherapy, 2004, Volume: 15, Issue:3

    Topics: alpha-Glucosidases; Animals; Antiviral Agents; Bovine Virus Diarrhea-Mucosal Disease; Cattle; Cell Line; Cytopathogenic Effect, Viral; Diarrhea Viruses, Bovine Viral; Disease Models, Animal; Drug Synergism; Enzyme Inhibitors; Glycoside Hydrolase Inhibitors; Hepacivirus; Hepatitis C; Humans; Indolizines; Inhibitory Concentration 50; Interferon-alpha; Reverse Transcriptase Polymerase Chain Reaction; Ribavirin; RNA, Viral; Viral Envelope Proteins; Viral Plaque Assay

2004
Primary infection of mice with high titer inoculum respiratory syncytial virus: characterization and response to antiviral therapy.
    Canadian journal of physiology and pharmacology, 2005, Volume: 83, Issue:2

    Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antiviral Agents; Bronchoalveolar Lavage Fluid; Cytokines; Disease Models, Animal; Lung; Mice; Mice, Inbred BALB C; Palivizumab; Respiratory Function Tests; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Ribavirin; Viral Proteins; Virus Replication

2005
Targeted therapy of respiratory syncytial virus by 2-5A antisense.
    Nucleosides, nucleotides & nucleic acids, 2005, Volume: 24, Issue:5-7

    Topics: Animals; Chlorocebus aethiops; Disease Models, Animal; DNA, Viral; Drug Therapy, Combination; Endoribonucleases; Genome, Viral; Humans; Interferons; Mice; Oligonucleotides, Antisense; Rats; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Ribavirin; RNA; RNA, Viral; Species Specificity

2005
Ribavirin and cysteinyl leukotriene-1 receptor blockade as treatment for severe bronchiolitis.
    Antiviral research, 2006, Volume: 69, Issue:2

    Topics: Acetates; Animals; Antiviral Agents; Bronchiolitis, Viral; Cyclopropanes; Cysteine; Disease Models, Animal; Drug Therapy, Combination; Humans; Leukotriene Antagonists; Leukotrienes; Lung; Mice; Mice, Inbred C57BL; Murine pneumonia virus; Pneumovirus Infections; Quinolines; Ribavirin; Sulfides; Treatment Outcome; Virus Replication

2006
Poly(I)-poly(C12U) but not ribavirin prevents death in a hamster model of Nipah virus infection.
    Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:5

    Topics: Animals; Cell Survival; Chlorocebus aethiops; Cricetinae; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; HeLa Cells; Humans; Immunoglobulin G; Injections, Intraperitoneal; Lethal Dose 50; Male; Mesocricetus; Nipah Virus; Poly I-C; Reverse Transcriptase Polymerase Chain Reaction; Ribavirin; Vero Cells; Viral Load

2006
Evaluation by Q-RTPCR of the efficacy of ribavirin complexed with beta-cyclodextrin against measles virus in a mouse encephalitis model.
    Pathologie-biologie, 2006, Volume: 54, Issue:10

    Topics: Animals; Antiviral Agents; beta-Cyclodextrins; Disease Models, Animal; Drug Therapy, Combination; Encephalitis, Viral; Measles; Measles virus; Mice; Mice, Inbred CBA; Reverse Transcriptase Polymerase Chain Reaction; Ribavirin

2006
Ribavirin, human convalescent plasma and anti-beta3 integrin antibody inhibit infection by Sin Nombre virus in the deer mouse model.
    The Journal of general virology, 2007, Volume: 88, Issue:Pt 2

    Topics: Abciximab; Animals; Antibodies; Antibodies, Monoclonal; Antiviral Agents; Disease Models, Animal; Hantavirus Pulmonary Syndrome; Humans; Immune Sera; Immunoglobulin Fab Fragments; Integrin beta3; Peromyscus; Rabbits; Ribavirin; Sin Nombre virus; Treatment Outcome

2007
A dengue fever viremia model in mice shows reduction in viral replication and suppression of the inflammatory response after treatment with antiviral drugs.
    The Journal of infectious diseases, 2007, Mar-01, Volume: 195, Issue:5

    Topics: 1-Deoxynojirimycin; Animals; Antiviral Agents; Dengue; Disease Models, Animal; Dose-Response Relationship, Drug; Indolizines; Mice; Ribavirin; Time Factors; Tubercidin; Viremia; Virus Replication

2007
Effect of oral gavage treatment with ZnAL42 and other metallo-ion formulations on influenza A H5N1 and H1N1 virus infections in mice.
    Antiviral chemistry & chemotherapy, 2007, Volume: 18, Issue:3

    Topics: Administration, Oral; Aluminum Compounds; Animals; Antiviral Agents; Disease Models, Animal; Female; Humans; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H5N1 Subtype; Manganese; Mice; Mice, Inbred BALB C; Orthomyxoviridae Infections; Oxygen; Ribavirin; Selenium; Specific Pathogen-Free Organisms; Survival Analysis; Zinc Compounds

2007
Therapeutic effects of combined treatment with ribavirin and tiazofurin on experimental autoimmune encephalomyelitis development: clinical and histopathological evaluation.
    Journal of the neurological sciences, 2008, Apr-15, Volume: 267, Issue:1-2

    Topics: Animals; Antimetabolites, Antineoplastic; Antiviral Agents; Central Nervous System; Chemotaxis, Leukocyte; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Encephalomyelitis, Autoimmune, Experimental; Gliosis; Immunosuppression Therapy; Male; Multiple Sclerosis; Myelin Sheath; Rats; Ribavirin; Treatment Outcome; Wallerian Degeneration

2008
MegaRibavirin aerosol for the treatment of influenza A virus infections in mice.
    Antiviral research, 2008, Volume: 78, Issue:3

    Topics: Aerosols; Animals; Antiviral Agents; Disease Models, Animal; Female; Humans; Influenza A Virus, H3N2 Subtype; Influenza, Human; Mice; Nebulizers and Vaporizers; Orthomyxoviridae Infections; Ribavirin; Treatment Outcome

2008
Murine trophoblast failure and spontaneous abortion.
    American journal of reproductive immunology (New York, N.Y. : 1989), 1993, Volume: 29, Issue:4

    Topics: Abortion, Spontaneous; Animals; Disease Models, Animal; Female; Fetal Resorption; Male; Mice; Mice, Inbred C3H; Mice, Inbred CBA; Mice, Inbred DBA; Pregnancy; Ribavirin; T-Lymphocytes, Regulatory; Trophoblasts

1993
Antiviral efficacy and toxicity of ribavirin in murine acquired immunodeficiency syndrome model.
    Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association, 1996, Aug-15, Volume: 12, Issue:5

    Topics: Acquired Immunodeficiency Syndrome; Animals; Antiviral Agents; Blood Cell Count; CD4-CD8 Ratio; Cell Division; Concanavalin A; Disease Models, Animal; Female; Immunoglobulin M; Leukemia Virus, Murine; Lymph Nodes; Mice; Mice, Inbred C57BL; Murine Acquired Immunodeficiency Syndrome; Organ Size; Ribavirin; Spleen

1996
Inhibition of influenza virus infections in mice by GS4104, an orally effective influenza virus neuraminidase inhibitor.
    Antiviral research, 1998, Volume: 37, Issue:2

    Topics: Acetamides; Administration, Intranasal; Administration, Oral; Amines; Animals; Antiviral Agents; Cell Line; Disease Models, Animal; Dogs; Enzyme Inhibitors; Female; Guanidines; Humans; Influenza A virus; Influenza B virus; Influenza, Human; Lung Diseases; Mice; Mice, Inbred BALB C; Molecular Structure; Neuraminidase; Oseltamivir; Pyrans; Ribavirin; Sialic Acids; Zanamivir

1998
Mouse model of respiratory syncytial virus infection to evaluate antiviral activity in vivo.
    Antiviral chemistry & chemotherapy, 1999, Volume: 10, Issue:3

    Topics: Animals; Antiviral Agents; Cyclophosphamide; Disease Models, Animal; Female; HeLa Cells; Humans; Immunocompromised Host; Immunosuppressive Agents; Lung; Lung Diseases, Interstitial; Mice; Mice, Inbred BALB C; Rats; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Ribavirin

1999
Use of cotton rats to evaluate the efficacy of antivirals in treatment of measles virus infections.
    Antimicrobial agents and chemotherapy, 2000, Volume: 44, Issue:5

    Topics: Animals; Antiviral Agents; Disease Models, Animal; Measles; Measles virus; Mice; Microbial Sensitivity Tests; Polymers; Rats; Ribavirin; Ribonucleosides; Sigmodontinae; Sulfonic Acids; Tumor Cells, Cultured

2000
In vivo influenza virus-inhibitory effects of the cyclopentane neuraminidase inhibitor RJW-270201.
    Antimicrobial agents and chemotherapy, 2001, Volume: 45, Issue:3

    Topics: Acetamides; Acids, Carbocyclic; Animals; Antiviral Agents; Cyclopentanes; Disease Models, Animal; Female; Guanidines; Influenza A virus; Influenza B virus; Lung; Mice; Mice, Inbred C57BL; Neuraminidase; Orthomyxoviridae Infections; Oseltamivir; Respiratory Function Tests; Ribavirin; Virus Replication

2001
Ribavirin induces error-prone replication of GB virus B in primary tamarin hepatocytes.
    Journal of virology, 2001, Volume: 75, Issue:17

    Topics: Animals; Antiviral Agents; Cells, Cultured; Disease Models, Animal; Flaviviridae; Guanosine; Hepatitis, Viral, Animal; Hepatocytes; Mycophenolic Acid; Polymerase Chain Reaction; Ribavirin; RNA, Viral; Saguinus; Virus Replication

2001
Intranasal challenge of mice with herpes simplex virus: an experimental model for evaluation of the efficacy of antiviral drugs.
    The Journal of infectious diseases, 1976, Volume: 133 Suppl

    Topics: Animals; Antiviral Agents; Cytarabine; Disease Models, Animal; Drug Evaluation, Preclinical; Encephalitis; Herpesviridae Infections; Idoxuridine; Interferons; Mice; Ribavirin; Simplexvirus; Vidarabine

1976
The activity of iododeoxyuridine, adenine arabinoside, cytosine arabinoside, ribavirin and phosphonoacetic acid against herpes virus in the hairless mouse model.
    The Journal of antimicrobial chemotherapy, 1977, Volume: 3 Suppl A

    Topics: Acetates; Animals; Cytarabine; Disease Models, Animal; Herpes Simplex; Idoxuridine; Kinetics; Mice; Mice, Nude; Organophosphonates; Ribavirin; Ribonucleosides; Simplexvirus; Vidarabine

1977
Comparative evaluation of antiherpetic drugs in animal experiments.
    Advances in ophthalmology = Fortschritte der Augenheilkunde = Progres en ophtalmologie, 1979, Volume: 38

    Topics: Animals; Brain Diseases; Disease Models, Animal; Evaluation Studies as Topic; Herpes Simplex; Immunocompetence; Keratitis, Dendritic; Mice; Organophosphorus Compounds; Peritoneal Diseases; Phosphonoacetic Acid; Rabbits; Ribavirin; Ribonucleosides; Vidarabine

1979
Influenza virus infection of hamsters. A model for evaluating antiviral drugs.
    Archives of virology, 1977, Volume: 54, Issue:1-2

    Topics: Administration, Intranasal; Animals; Antibodies, Viral; Antiviral Agents; Cricetinae; Disease Models, Animal; Drug Evaluation, Preclinical; Hemagglutination Inhibition Tests; Influenza A virus; Lung; Male; Mesocricetus; Nasal Mucosa; Orthomyxoviridae Infections; Pyrans; Ribavirin; Ribonucleosides; Terpenes; Trachea

1977
Arenavirus infection in the guinea pig model: antiviral therapy with recombinant interferon-alpha, the immunomodulator CL246,738 and ribavirin.
    Antiviral research, 1989, Volume: 12, Issue:5-6

    Topics: Acridines; Adjuvants, Immunologic; Animals; Antiviral Agents; Arenaviridae Infections; Disease Models, Animal; Female; Guinea Pigs; Interferon Type I; Male; Precipitin Tests; Recombinant Proteins; Ribavirin; Ribonucleosides

1989
Pathogenesis and preventive and therapeutic trials in an animal model of dilated cardiomyopathy induced by a virus.
    Japanese circulation journal, 1987, Volume: 51, Issue:6

    Topics: Animals; Autoantibodies; Cardiomyopathy, Dilated; Disease Models, Animal; Encephalomyocarditis virus; Endomyocardial Fibrosis; Enterovirus Infections; Immunity, Maternally-Acquired; Interferon Type I; Isoenzymes; Mice; Mice, Inbred DBA; Myocarditis; Myocardium; Myosins; Recombinant Proteins; Ribavirin; Viral Vaccines

1987
Aerosol administration of antiviral agents to treat lung infection due to murine cytomegalovirus.
    The Journal of infectious diseases, 1988, Volume: 157, Issue:2

    Topics: Acyclovir; Administration, Oral; Aerosols; Animals; Antiviral Agents; Cytomegalovirus Infections; Disease Models, Animal; Female; Foscarnet; Ganciclovir; Mice; Mice, Inbred BALB C; Phosphonoacetic Acid; Pneumonia, Viral; Pregnancy; Pregnancy Complications, Infectious; Ribavirin

1988
Ribavirin effect on experimental Junin virus-induced encephalitis.
    Journal of medical virology, 1988, Volume: 26, Issue:1

    Topics: Animals; Arenaviruses, New World; Brain; Disease Models, Animal; Encephalitis; Hemorrhagic Fever, American; Macrophages; Peritoneal Cavity; Rats; Ribavirin; Ribonucleosides; Virus Replication

1988
Experimental studies of arenaviral hemorrhagic fevers.
    Current topics in microbiology and immunology, 1987, Volume: 134

    Topics: Animals; Arenaviridae; Arenaviridae Infections; Cricetinae; Disease Models, Animal; Guinea Pigs; Haplorhini; Hemorrhagic Fever, American; Hemorrhagic Fevers, Viral; Immune Tolerance; Lassa Fever; Lymphocytic Choriomeningitis; Mice; Ribavirin

1987